TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-47.31%
Change (1 year)
Categories
EPS for TherapeuticsMD (TXMD)
EPS in 2023 (TTM): $4.81
According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is $4.81. In 2022 the company made an earnings per share (EPS) of $12.55 an increase over its 2021 EPS that were of -$21.70.
EPS history for TherapeuticsMD from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $4.81 | -61.67% |
| 2022 | $12.55 | -157.83% |
| 2021 | -$21.70 | -35.22% |
| 2020 | -$33.50 | -5.63% |
| 2019 | -$35.50 | 20.34% |
| 2018 | -$29.50 | 55.26% |
| 2017 | -$19.00 | -19.15% |
| 2016 | -$23.50 | -6% |
| 2015 | -$25.00 | 42.86% |
| 2014 | -$17.50 | 52.17% |
| 2013 | -$11.50 | -41.03% |
| 2012 | -$19.50 | -93.62% |
| 2011 | -$305.78 | -65.57% |
| 2010 | -$888.07 | 88.66% |
| 2009 | -$470.73 | -32.78% |
| 2008 | -$700.29 | 16.59% |
| 2007 | -$600.66 | 26.96% |
| 2006 | -$473.11 | -11743.27% |
| 2005 | $4.06 | -101.88% |
| 2004 | -$216.02 | -554.77% |
| 2003 | $47.50 | 216.55% |
| 2002 | $15.01 | -85.01% |
| 2001 | $100.11 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -61.33% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -23.48% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$39.56 | -922.45% | 🇺🇸 USA |
 Royalty Pharma RPRX | $0.55 | -88.57% | 🇬🇧 UK |
 Lannett Company LCI | -$25.28 | -625.57% | 🇺🇸 USA |